A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer.

Alison M. Dunning(University of Cambridge), James C. Metcalfe, Simon McBride, Vesa Kataja(South Eastern Finland University of Applied Sciences), Peter Ellis(Wellcome Sanger Institute), Robert Luben(University of Cambridge), Heidi L Kirschenlohr, Paul D.P. Pharoah(Apple (Israel)), Bruce A.J. Ponder(University of Cambridge), Douglas F. Easton, Paul R. Kemp(Imperial College London), Catherine S. Healey(University of Cambridge), Jenny Chang‐Claude(German Cancer Research Center)
PubMed
May 15, 2003
Cited by 374

Related Papers

Genome-wide association study identifies novel breast cancer susceptibility loci
|Nature|2007|2.3k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
High burden and pervasive positive selection of somatic mutations in normal human skin
|Science|2015|1.8k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k